Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPOCx-iRex Trial: Hypofractionated whole-pelvic concurrent chemoradiotherapy with optimized image-guided adaptive brachytherapy in cervical cancer
TCTR20210812003Phase 3Active, not recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 3, randomised trial in Cervical Cancer (CC) (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jul 2021; status: active, not recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on TCTR20210812003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210812003.